Logo image of XAIR

BEYOND AIR INC (XAIR) Stock Fundamental Analysis

NASDAQ:XAIR - Nasdaq - US08862L1035 - Common Stock - Currency: USD

2.86  -0.12 (-4.03%)

After market: 2.84 -0.02 (-0.7%)

Fundamental Rating

3

Taking everything into account, XAIR scores 3 out of 10 in our fundamental rating. XAIR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of XAIR have multiple concerns. XAIR is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year XAIR has reported negative net income.
XAIR had a negative operating cash flow in the past year.
XAIR had negative earnings in each of the past 5 years.
In the past 5 years XAIR always reported negative operating cash flow.
XAIR Yearly Net Income VS EBIT VS OCF VS FCFXAIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

XAIR has a worse Return On Assets (-155.10%) than 90.91% of its industry peers.
With a Return On Equity value of -343.26%, XAIR is not doing good in the industry: 83.96% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -155.1%
ROE -343.26%
ROIC N/A
ROA(3y)-114.02%
ROA(5y)-88.4%
ROE(3y)-243.66%
ROE(5y)-173.09%
ROIC(3y)N/A
ROIC(5y)N/A
XAIR Yearly ROA, ROE, ROICXAIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400 -600 -800 -1K

1.3 Margins

XAIR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XAIR Yearly Profit, Operating, Gross MarginsXAIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K -5K

More info and screens

3

2. Health

2.1 Basic Checks

XAIR does not have a ROIC to compare to the WACC, probably because it is not profitable.
XAIR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, XAIR has less shares outstanding
Compared to 1 year ago, XAIR has a worse debt to assets ratio.
XAIR Yearly Shares OutstandingXAIR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
XAIR Yearly Total Debt VS Total AssetsXAIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -17.18, we must say that XAIR is in the distress zone and has some risk of bankruptcy.
XAIR's Altman-Z score of -17.18 is on the low side compared to the rest of the industry. XAIR is outperformed by 87.70% of its industry peers.
XAIR has a Debt/Equity ratio of 0.68. This is a neutral value indicating XAIR is somewhat dependend on debt financing.
XAIR has a worse Debt to Equity ratio (0.68) than 68.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Altman-Z -17.18
ROIC/WACCN/A
WACC8.18%
XAIR Yearly LT Debt VS Equity VS FCFXAIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

XAIR has a Current Ratio of 3.20. This indicates that XAIR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of XAIR (3.20) is comparable to the rest of the industry.
A Quick Ratio of 2.72 indicates that XAIR has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.72, XAIR is doing good in the industry, outperforming 61.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.2
Quick Ratio 2.72
XAIR Yearly Current Assets VS Current LiabilitesXAIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

More info and screens

7

3. Growth

3.1 Past

XAIR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -193.96%.
Looking at the last year, XAIR shows a very strong growth in Revenue. The Revenue has grown by 219.12%.
Measured over the past years, XAIR shows a very strong growth in Revenue. The Revenue has been growing by 21.66% on average per year.
EPS 1Y (TTM)-193.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)219.12%
Revenue growth 3YN/A
Revenue growth 5Y21.66%
Sales Q2Q%145.11%

3.2 Future

XAIR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.03% yearly.
XAIR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 125.33% yearly.
EPS Next Y95.14%
EPS Next 2Y40.3%
EPS Next 3Y26.03%
EPS Next 5YN/A
Revenue Next Year240.09%
Revenue Next 2Y186.15%
Revenue Next 3Y125.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XAIR Yearly Revenue VS EstimatesXAIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2023 2024 2025 2026 2027 2028 10M 20M 30M 40M
XAIR Yearly EPS VS EstimatesXAIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -1 -2 -3 -4 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XAIR. In the last year negative earnings were reported.
Also next year XAIR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XAIR Price Earnings VS Forward Price EarningsXAIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XAIR Per share dataXAIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

A more expensive valuation may be justified as XAIR's earnings are expected to grow with 26.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.3%
EPS Next 3Y26.03%

More info and screens

0

5. Dividend

5.1 Amount

XAIR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BEYOND AIR INC

NASDAQ:XAIR (8/1/2025, 8:11:28 PM)

After market: 2.84 -0.02 (-0.7%)

2.86

-0.12 (-4.03%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)06-17 2025-06-17/amc
Earnings (Next)08-04 2025-08-04
Inst Owners22.27%
Inst Owner Change0.6%
Ins Owners14.24%
Ins Owner Change11.85%
Market Cap13.27M
Analysts80
Price Target45.9 (1504.9%)
Short Float %N/A
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.88%
Min EPS beat(2)8.09%
Max EPS beat(2)27.68%
EPS beat(4)4
Avg EPS beat(4)13.93%
Min EPS beat(4)3.34%
Max EPS beat(4)27.68%
EPS beat(8)7
Avg EPS beat(8)10.97%
EPS beat(12)8
Avg EPS beat(12)5.18%
EPS beat(16)8
Avg EPS beat(16)-11.58%
Revenue beat(2)1
Avg Revenue beat(2)-2.96%
Min Revenue beat(2)-18.64%
Max Revenue beat(2)12.72%
Revenue beat(4)1
Avg Revenue beat(4)-11.74%
Min Revenue beat(4)-24.93%
Max Revenue beat(4)12.72%
Revenue beat(8)1
Avg Revenue beat(8)-29.2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1900%
PT rev (3m)1900%
EPS NQ rev (1m)-1900%
EPS NQ rev (3m)-1426.32%
EPS NY rev (1m)31.82%
EPS NY rev (3m)31.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.25%
Revenue NY rev (1m)-5.21%
Revenue NY rev (3m)-5.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.58
P/FCF N/A
P/OCF N/A
P/B 0.98
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)-5.35
EYN/A
EPS(NY)-0.26
Fwd EYN/A
FCF(TTM)-9.5
FCFYN/A
OCF(TTM)-8.24
OCFYN/A
SpS0.8
BVpS2.93
TBVpS2.66
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -155.1%
ROE -343.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-114.02%
ROA(5y)-88.4%
ROE(3y)-243.66%
ROE(5y)-173.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 183.61%
Cap/Sales 158.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.2
Quick Ratio 2.72
Altman-Z -17.18
F-Score3
WACC8.18%
ROIC/WACCN/A
Cap/Depr(3y)311.89%
Cap/Depr(5y)350.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-193.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-400%
EPS Next Y95.14%
EPS Next 2Y40.3%
EPS Next 3Y26.03%
EPS Next 5YN/A
Revenue 1Y (TTM)219.12%
Revenue growth 3YN/A
Revenue growth 5Y21.66%
Sales Q2Q%145.11%
Revenue Next Year240.09%
Revenue Next 2Y186.15%
Revenue Next 3Y125.33%
Revenue Next 5YN/A
EBIT growth 1Y29.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year98.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.77%
OCF growth 3YN/A
OCF growth 5YN/A